Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families
- PMID: 18446368
- PMCID: PMC12161732
- DOI: 10.1007/s00432-008-0399-x
Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families
Abstract
Background: von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germline mutations in the VHL gene. To date, more than 500 VHL families have been reported worldwide. However, few information is available about VHL germline mutations in mainland Chinese families.
Objective: To provide some preliminary information about the germline VHL mutations in mainland Chinese population.
Methods: A total of 27 index patients suspected of having VHL disease from unrelated Chinese families were studied by using direct DNA sequencing analysis and universal primer quantitative fluorescent multiplex polymerase chain reaction.
Results: The VHL germline mutations were detected in 26 (96%) probands. A total of 20 intragenic mutations (77%) were identified consisting of 12 missenses, 5 nonsenses, 2 micro-deletions and 1 novel intron mutation (IVS1-38C>T). Six large deletions (23%) were detected including four partial deletions and two complete deletions. Furthermore, a C>T substitution at nucleotide 470 (Pro86Leu) was observed in two unrelated Chinese families. Of note, two mutations (Asn78Ser and Ser80Ile) previously characterized as VHL type I mutations in Western VHL were associated with the type II Chinese family. In addition, a VHL germline mutation was also identified in a proband who did not fulfill the clinical diagnostic criteria for VHL disease.
Conclusions: The spectrum of VHL germline mutations in mainland Chinese population is similar to that observed in Western population, and Genetic testing can be powerful in diagnosis and clinical management of VHL disease.
Figures



Similar articles
-
[Large germline deletion of the VHL gene in Chinese families with von Hippel-Lindau syndrome].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Oct;26(5):539-41. doi: 10.3760/cma.j.issn.1003-9406.2009.05.014. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009. PMID: 19806577 Chinese.
-
Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients.J Hum Genet. 2012 Apr;57(4):238-43. doi: 10.1038/jhg.2012.10. Epub 2012 Feb 23. J Hum Genet. 2012. PMID: 22357542
-
Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease.Int J Mol Med. 2012 Jan;29(1):47-52. doi: 10.3892/ijmm.2011.808. Epub 2011 Oct 4. Int J Mol Med. 2012. PMID: 21972040
-
Testing for germline mutations in sporadic pheochromocytoma/paraganglioma: a systematic review.Clin Endocrinol (Oxf). 2015 Mar;82(3):338-45. doi: 10.1111/cen.12530. Epub 2014 Jul 7. Clin Endocrinol (Oxf). 2015. PMID: 24954084
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
Cited by
-
Identification of 3 novel VHL germ-line mutations in Danish VHL patients.BMC Med Genet. 2012 Jul 16;13:54. doi: 10.1186/1471-2350-13-54. BMC Med Genet. 2012. PMID: 22799452 Free PMC article.
-
Clinical and genetic investigation of a multi-generational Chinese family afflicted with Von Hippel-Lindau disease.Chin Med J (Engl). 2015 Jan 5;128(1):32-8. doi: 10.4103/0366-6999.147802. Chin Med J (Engl). 2015. PMID: 25563310 Free PMC article.
-
De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.J Neurosurg. 2014 Aug;121(2):384-386. doi: 10.3171/2014.2.JNS131190. Epub 2014 Mar 28. J Neurosurg. 2014. PMID: 24678776 Free PMC article.
-
Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months.Fam Cancer. 2012 Jun;11(2):209-14. doi: 10.1007/s10689-011-9503-5. Fam Cancer. 2012. PMID: 22203439
-
Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel-Lindau (VHL) disease.J Hum Genet. 2014 Sep;59(9):488-93. doi: 10.1038/jhg.2014.61. Epub 2014 Jul 31. J Hum Genet. 2014. PMID: 25078357
References
-
- Ashida S, Furihata M, Tanimura M, Suqita O, Yamashita M, Miura T, Moriyama M, Shuin T (2003) Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status. J Urol 169:2089–2093 - PubMed
-
- Ashida S, Okoda H, Chikazawa M, Tanimura M, Suqita O, Yamamoto Y, Nakamura S, Moriyama M, Shuin T (2000) Detection of circulating cancer cells with von Hippel–Lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin Cancer Res 6:3817–3822 - PubMed
-
- Banks RE, Tirukonda P, Taylor C, Hornigold N, Astuti D, Cohen D, Maher ER, Stanley AJ, Harnden P, Joyce A, Knowles M, Selby P (2006) Genetic and epigenetic analysis of von Hippel–Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res 66:2000–2011 - PubMed
-
- Catapano D, Muscarella LA, Guarnieri V, Zelante L, D’Angelo VA, D’Agruma L (2005) Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Neurosurgery 56:1215–1221 - PubMed
-
- Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman M, Zbar B (1995) Germline mutations in the von Hippel–Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66–75 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical